Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia
2 other identifiers
observational
22
1 country
1
Brief Summary
Nosocomial pneumonia in the Intensive Care Unit is often not properly diagnosed mainly due to ongoing antimicrobial therapy. The study investigates the feasibility of more advanced diagnostic technics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 19, 2020
CompletedFirst Posted
Study publicly available on registry
February 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 22, 2021
April 1, 2021
6.7 years
February 19, 2020
April 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ratio of patients where the advanced methods are superior to routine
Ratio of patients diagnosed by 16s, 18s or NGS to total number of patients compared to ratio of patients diagnosed by routine method (culture)
1 day
Study Arms (1)
Adults with nosocomial pneumonia
Diagnostic procedures on pulmonary secretion collected by tracheal suctioning and bronchoalveolar lavage.
Interventions
Culture, 16s, 18s, next generation sequencing
Eligibility Criteria
Adult patients with nosocomial pneumonia and the need of mechanical ventilation not intubated for more than 24 hours.
You may qualify if:
- Patients intubated because of respiratory failure following nosocomial pneumonia
You may not qualify if:
- Terminal patients
- Patients with lung cancer
- Intubated for more than 24 hours at the sampling time
- Not fulfilling the CDC criteria for nosocomial pneumonia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zealand University Hospitallead
- Slagelse Hospitalcollaborator
Study Sites (1)
Zealand University Hospital
Køge, Region Sjælland, 4600, Denmark
Biospecimen
Pulmonary secretion
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lone Musaeus Poulsen, MD
Zealand University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2020
First Posted
February 21, 2020
Study Start
May 1, 2014
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
April 22, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share